We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Molecular Assays Detect Enterovirus in Clinical Samples

By LabMedica International staff writers
Posted on 02 May 2012
The detection of Enterovirus (EV) ribonucleic acid (RNA) based on molecular methods is a quicker and more sensitive approach than culture techniques. More...


Different real-time polymerase chain reaction assays (PCR) assays and protocols for EV RNA detection are available, but comparisons of results obtained according to the different approaches are limited and many of these molecular assays are laborious and time-consuming.

Scientists at the Hospital Sant Joan de Déu (Barcelona, Spain) evaluated an in-house real-time reverse transcription (RT-PCR) assay with a commercialized TaqMan real-time RT-PCR kit for detection of EV. They tested and analyzed 132 patient samples between July and November 2010. These were consecutive clinical specimens from pediatric patients less than six years old with clinical suspicion of EV infection.

The optimized one-step RT-PCR amplification reactions were undertaken in a single reaction tube using the Enterovirus real-time RT-PCR microplate system (TaqMan) kit, MutaPLATE Enterovirus (Immundiagnostik AG; Bensheim, Germany). The in-house reaction of a one-step RT-PCR amplification was performed in a single reaction tube using the primers and probe synthesized by Applied Biosystems (Foster City, CA, USA).

A total of 153 samples from 132 patients were collected during the study period. There were 68 males (51.5%) and 64 females (48.5%); the age of patients ranged from 3 days to 72 months. Samples were collected from patients with suspicion of EV infection who presented fever without focus or viral meningitis. The samples tested included 101 (66%) plasmas, 51 (33.3%) cerebrospinal fluids (CSF), and 1 (0.7%) vesicle.

A total of 19 of 132 patients (14.4%) involving 20 samples (14 plasma and six CSF samples) were positive in at least one of the two assays. The sensitivity of the in-house assay when the MutaPLATE assay was used as a reference was 90% and the specificity was 100%. The authors concluded that the two real-time RT-PCR assays are rapid and easy methods for detection of EV and contribute positively to rational and specific management of the etiological cause of fever in children.

Enteroviruses are RNA viruses belonging to the Picornaviridae family. EV infections are common, especially in young children, and are associated with a multitude of clinical manifestations. The study was published in the May 2012 issue of the European Journal of Clinical Microbiology & Infectious Diseases.

Related Links:

Hospital Sant Joan de Déu
Immundiagnostik AG
Applied Biosystems




Gold Member
Immunochromatographic Assay
CRYPTO Cassette
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Pipette
Accumax Smart Series
Gold Member
Hybrid Pipette
SWITCH
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: Residual leukemia cells may predict long-term survival in acute myeloid leukemia (Photo courtesy of Shutterstock)

MRD Tests Could Predict Survival in Leukemia Patients

Acute myeloid leukemia is an aggressive blood cancer that disrupts normal blood cell production and often relapses even after intensive treatment. Clinicians currently lack early, reliable markers to predict... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.